SWS Partners’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
EAM
SIMG
RG
SWS Partners's GH Position: Q2 2026 in Review
SWS Partners reduced its Guardant Health (GH) stake by 6.2% in Q2 2026, selling an estimated $533K and leaving 74,582 shares worth $11.2M. The position accounts for 2.42% of the portfolio, ranked #9.
SWS Partners first reported a position in GH in Q1 2022 and has held it in 18 quarters since. 190 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- SWS Partners held 74,582 shares of Guardant Health worth $11.2M as of Q2 2026.
- SWS Partners sold 4,899 Guardant Health shares in Q2 2026, an estimated $533K.
- Guardant Health made up 2.42% of SWS Partners's portfolio in Q2 2026, its #9 holding.
- SWS Partners first reported a position in Guardant Health in Q1 2022 and has held it in 18 quarters since.
- 190 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on SWS Partners's 13F filing for Q2 2026, filed 3 Aug 2026.